MediBloc

We note the following general strengths of the MediBloc project:

• The team has a good track record.
• Complex yet necessary idea.
• Good competitive position.
• Transparency of the team in terms of financial statements and activities.
• Successes in Business Development and partnerships (in South Korea so far).
• Modest financial performance of the MED token.

At this stage the key risks associated with the project include:

Absence of a publicly available MVP/alpha/beta/testnet of the blockchain - Although it was not due to be released by the date of the analysis, it is still worth noting that the team does not yet have a publicly available MVP/beta or testnet of their blockchain, which increases the risk for potential investors. We note that the Software Development Kit (SDK) has been released as planned, so the team appears to be overall on track with the project. We also note that the team has provided us with demonstration video of a product developed for hospitals, so the risk is partially offset.

Development risks - The project’s roadmap and the actual performance of the team during the first five months of 2018 show that the planned development is justified and achievable. However, developing one’s own blockchain requires a significant amount effort from the team both in terms of work to be done and expertise. Once alpha/beta of the testnet and the mainnet are released, the degree of this risk may go down.

Business/commercial risks – The MediBloc project currently seems to be primarily targeting the South Korean market. While this is totally acceptable at this point in time, we believe that the project should also aim for the global market, as well. Though, it is worth noting that the healthcare system is different in almost every country, which may cause problems when expanding overseas.

Team competence - Most of the LinkedIn accounts of the team members do not have evidence of expertise (endorsements or recommendations). Though, we must mention that LinkedIn is not a commonly used platform in South Korea, so this risk is partially explained and offset by this fact. Overall, the team has has been strengthened and seems to have enough expertise to deliver the project even taking into account the decision to develop own blockchain.

MediBloc is set to revolutionize the way healthcare data is shared between providers, and is backed up by a team of industry experts and a solid white paper. If you’re interested in seeing how blockchain technology can improve aging healthcare industry data infrastructure, Medibloc is worth investigation.